Generating a phosphate prodrug is one of the common approaches for circumventing poor solubility issues of a parent drug. Alkaline phosphatase level was determined in rat intestine mucosa scraps, Caco-2 cell and MDCK cell to characterize in vitro models for alkaline phosphatase mediated phosphate prodrug conversion. In addition, fosphenytoin and fosfluconazole were used as probe prodrugs to evaluate the models. The highest amount of ALP was detected in rat intestinal mucosa scraps, while alkaline phosphatase in 5-day cultured MDCK cells was minimal. As anticipated, alkaline phosphatase levels correlated with the parent drug conversion, and the shortest cleavage half-life (t 1/2 ) was observed in rat mucosa scraps and MDCK cells showed the slowest conversion. Furthermore, the polarized conversion for the prodrugs was observed 
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INTRODUCTION
Poor aqueous solubility could be a serious barrier for the successful delivery of a therapeutic candidate for both oral and parenteral administrations. For oral delivery, drugs with poor aqueous solubility often show low or erratic bioavailability, such as large pill size or/and certain food and water restrictions are required. In parenteral use, the drug candidates with poor water solubility often requires a large injection volume for dissolving the drug mass and longer injection time, which may cause side effects, such as local irritation at the injection site or erratic systemic delivery due to the possible crystallization at the local administrative site. Phosphate prodrugs are one of the effective and most commonly used approaches employed to overcome these issues in drug delivery (Fleisher et al., 1996) . By introducing an ionizable phosphate group to the parent drug molecule, phosphate prodrugs are usually highly water soluble. Most importantly phosphate prodrugs are readily cleaved by alkaline phosphatase (ALP), an enzyme widely distributed in plasma and variety of tissues, to their parent drugs (Fleisher et al., 1985; Fleisher et al., 1996) . This approach has been successfully used for a number of oral and parenterally administered drug candidates on the market (de Jong et al., 1997) .
Due to the introduction of ionic and polar features, a phosphate prodrug usually has inherent low permeability than its parent drug molecule. There is abundant ALP expressed on intestine epithelial membrane cells, therefore, when orally administrated, a phosphate prodrug is rapidly cleaved to its parent drug before the parent drug is absorbed into the systemic circulation (Fleisher et al., 1985; Amidon et al., 1995; Kasim et al., 2004) . To achieve the maximal absorption, it is ideally required that the poorly soluble parent drug possesses high permeability, known as class II compounds in the DMD #26245 biopharmaceutical classification system (BCS) (Amidon et al., 1995; Fleisher et al., 1996; Kasim et al., 2004) . The anti-viral drug, fosamprenavir, serves as an example of a phosphate prodrug converted its parent drug, amprenavir, by ALP located in intestine epithelial membranes. The highly permeable parent drug, amprenavir, is subsequently rapidly absorbed (Becker and Thornton, 2004; Furfine et al., 2004) . However, there are many phosphate prodrugs which fail to achieve an acceptable oral profile, so the phosphate prodrug approach still remains a challenge for providing an oral delivery option. Therefore, efficient in vitro screening tools for phosphate prodrug bioconversion and absorption assessment are needed at an early stage of drug discovery in the pharmaceutical industry.
In in vivo, ALP is broadly distributed in plasma, the brush broader membrane of gastrointestinal tract and other soft tissues. ALP is also used as a marker of cell differentiation and polarity in in vitro cell cultures, as epithelial cells have demonstrated an asymmetric distribution of ALP on their luminal surface (Lai et al., 2002) . Human colon carcinoma cell line (Caco-2) is spontaneously differentiated and forms monolayer structure that highly mimics the intestine epithelium when cultured in vitro. ALP levels in Caco-2 cells are considered to be similar to that in human small intestine (Pinto et al., 1983) . Therefore, the Caco-2 cell monolayer has been utilized for the evaluation of phosphate prodrug bioconversion and permeation (Heimbach et al., 2003) . However, long-time culture of Caco-2 cell to achieve the differentiated characteristics limited the application of this model as a high throughput tool for the drug screening. Recently, Madin-Darby Canine Kidney (MDCK) cells have become an alternative to Caco-2 cells for high throughput screening of cell permeability of new chemicals entities, because it DMD #26245 6 requires less time to differentiate to form the monolayer morphology. Although ALP has been detected as a marker enzyme for differentiation of MDCK cells as well (Lai et al., 2002) , the efficiency of ALP mediated bioconversion of phosphate prodrugs in this cell model remains unknown. In this study, we investigated ALP mediated conversion of probe phosphate prodrugs, fosphenytoin and fosfluconazole, in rat intestine mucosa scraps, Caco-2 cells and MDCK cells. The results will provide the information for the in vitro model selection in phosphate drug screening.
MATERIALS AND METHODS
Chemicals and Reagents
Fosfluconazole and fosphenytoin ( Figure 1 
Rat Intestine Mucosa Scrap Preparation
Immediately after excising intestines from male Sprague-Dawley rats, a segment of about 1 meter small intestine was placed in an ice cold stainless dish and then washed with phosphate-buffered saline (PBS, pH 7.4) 
Quantification of ALP in Caco-2, MDCK Cells, Rat Intestine Mucosa Scraps
The homogenate of rat intestine mucosa scrap were prepared as described above. 
Bioconversion and Transwell Transport of Prodrugs in Caco-2 Cells
Caco-2 cells (ATCC, VA) were maintained in DMEM with 10% FBS, 1% nonessential amino acids, 1% glutamax, 1 mM sodium pyruvate and 0.06 mg/ml gentamicin. were determined by LC-MS/MS. The extent of permeation (Papp) was generated for both A→B and B→A transport. Both parental compounds and prodrugs were monitored. The concentration dependent bioconversions mediated by ALP were also conducted to investigate the kinetics of bioconversion.
ALP Mediated Prodrug Bioconversion in MDCK Cells
MDCK cells were maintained in DMEM-α media supplemented with 10% FBS, 100 units penicillin and 100 μg/ml streptomycin, 1% L-glutamine and 1% NEAA. The cells were grown on Millipore 24-well transwell plates for 4-5 days before transport assay. Similar to Caco-2 cells, the transport and bioconversion assays were conducted in live cells and initiated by applying the testing compounds to the donor chamber (either apical or basal chamber). The following procedures were similar to Caco-2 assays described above.
LC-MS/MS Analysis
An API 4000 triple quadrupole mass spectrometer (AB/MDS-Sciex, Concord, 
Data Analysis
The concentration-time profiles were fitted to a one compartment model using 
RESULTS
ALP in Intestinal Mucosa Scraps, MDCK and Caco-2 Cells
In the present study, we have evaluated the ALP amount in the in vitro models that might potentially be employed for the screening of ALP mediated phosphate prodrug bioconversion. As described above, the ALP levels in rat intestinal mucosa scraps, Caco-2 and MDCK cells were quantified by an ALP fluorescence detection kit. The results are shown in Figure 2 . The ALP in rat intestine scraps exhibited the highest level among the tested models. The ALP level detected in Caco-2 monolayers cultured for 21 days was about 10-fold less, compared to the rat intestinal mucosa scraps. The 5-day cultured MDCK monolayers expressed the least amount of ALP compared to other models.
Bioconversion of Fosphenytoin and Fosfluconazole in Intestinal Mucosa Scraps, MDCK and Caco-2 Cells
Fosphenytoin and fosfluconazole were used as probe substrates to assess the bioconversion of phosphate prodrugs. Initially, the disappearance of the phosphate prodrugs was monitored during the incubation. As anticipated based on ALP levels, the intestinal mucosa scraps demonstrated the shortest half-lives for the cleavage of fosphenytoin and fosfluconazole, compared to MDCK and Caco-2 monolayers. The overall clearance rate of both probe substrates was correlated with the amount of ALP detected in the individual model. In addition, we observed that the disappearance of fosphenytoin was faster than fosfluconazole in all tested models (Table 1 ). The apparent half-life for fosphenytoin bioconversion in rat mucosa scraps was 1.2 mins (Table 1) . In contrast, a flat disappearance slope was found for fosfluconazole when incubating with intestinal mucosa scraps, compared to bioconversion of fosphenytoin (Figure 3a) . More
This article has not been copyedited and formatted. The final version may differ from this version. flat disappearance slopes were observed in MDCK and Caco-2 monolayers for the cleavage of both probe substrates (Figure 3b,c) . The apparent half-life for fosfluconazole bioconversion in intestinal mucosa scraps was 10 minutes (Table 1) 
The Phosphate Prodrug Bioconversion and Transport in Caco-2 Monolayer
Caco-2 cells are spontaneously differentiated after reaching confluence when being cultured on a transwell membrane. The cells form polarized monolayers and express ALP activity at their apical membranes in the levels similar to those found in the human intestine (Pinto et al., 1983) . In the present study, the ALP dependent bioconversions of fosphenytoin and fosfluconazole in Caco-2 cells were also examined.
To investigate the polarized bioconversion and the transwell transport of phosphate prodrugs in Caco-2 monolayer, 10 μM fosfluconazole or fosphenytoin was dosed either in the apical or basal compartment in transwell plates. As shown in Figure 4 , both prodrugs were efficiently cleaved in the apical compartment following a 2-hour incubation. The converted parent drugs, phenytoin and fluconazole, were detected in the dosing chamber as well as in receiver chamber (Figure 4 ). In contrast, the bioconversions for both prodrugs were minimal or undetectable when dosing in the basal chamber. The results suggested the ALP mediated bioconversion occurred on apical side of Caco-2 monolayers. However, the prodrugs were not detectable in the receiver compartment irrespective of dosing in the apical or basal chamber, corroborate the poor permeability of 
DISCUSSION
Alkaline phosphatases are phosphatidylinositol-linked membrane hydrolase enzymes responsible for removing phosphate moiety from many type of molecules. At least four genes that encode distinct ALP proteins occur in different tissues: intestinal, placental, placental-like and liver/bone/kidney alkaline phosphatases (Henthorn et al., 1988) . The ALP level in blood represents the total amount of alkaline phosphatases released from these tissues. Based on the concept of in vivo bioconversion of alkaline phosphatases, phosphate ester prodrugs are designed to successfully overcome drug delivery problems that may compromise the therapeutic utility of a potential drug (Boucher, 1996; Becker and Thornton, 2004) . Through a direct incorporation of a phosphate moiety into the hydroxyl or amine functionalities of a parent drug, for instance, to form a phosphomonoester or attaching it to the parent drug via a chemical parent drug such as the prodrug of phenytoin, fosphenytoin (Luer, 1998) . A methylene spacer is also a very common linker that is used for the prodrug design. Such prodrugs release the parent via a two-step conversion process, an ALP mediated dephosphorylation followed by a fast spontaneous chemical breakdown of the hemiacetal intermediate (Figure 1 ). However, in terms of bioconversion mediated by ALPs, not all phosphate prodrugs undergo the desired rapid bioconversion to release the parent drug. For example, reports have shown that phosphomonoester of secondary and tertiary alcohols undergo slower rates of enzymatic conversion in vitro, while phosphomonoesters are better substrates for ALP than phosphoramidates (Kearney and Stella, 1992; Safadi et al., 1993; Vyas et al., 1993) . Therefore, in vitro/ in vivo models for evaluating bioconversion are potentially of great value at early stage of drug discovery.
In the present study, two probe compounds were selected as model compounds to study the in vitro bioconversion. One is the fosfluconazole (Figure 1 ) (Diflucan ® from
Pfizer Inc.), in which the phosphoryl group is linked on the tertiary alcohol of fluconazole.
Unlike the parent compound, fosfluconazole is more highly water-soluble (>300mg/mL vs 1 mg/mL) and chemically stable in the solid state and in aqueous solution (Yamreudeewong et al., 1993; Bentley et al., 2002) . Another substrate used in present study is fosphenytoin, in which the phosphoryl group is attached to NH group on the indole ring of phenytoin through a self-cleavable linker, the hydroxymethyl group ( Figure   1 ). With the hydroxymethyl linker, fosphenytoin conversion is fast and efficient in vivo (8.1 minutes), while fosfluconazole is hydrolyzed by alkaline phosphatases in blood and tissues with the t 1/2 of 1.5 to 2.5 hours (Boucher, 1996; Sobue et al., 2004 prodrug screening. In addition, as the preparation was isolated directly from tissues and could be pooled and stored at freezer for repeatedly using, the bioconversion data obtained from the model could offer the predictive information in in vivo situation.
Because of the similarity of the differentiated monolayer formed by Caco-2 cells with human intestinal mucosa, Caco-2 cells have been widely used to predict drug absorption in human. In the present study, Caco-2 cell showed the efficient bioconversion for probe phosphate prodrugs (Figure 4) . Simultaneously, the permeability of prodrug and parent drug molecules could also be determined. Recently, due to labor savings on cell maintenance, MDCK cells show promise as an alternative approach for permeability screening for predicting the in vivo absorption and has been gradually accepted by the pharmaceutical industry. However, the 5-day grown MDCK cells produced only minimal amount of alkaline phosphatase, therefore, MDCK monolayer was not be able to distinguish bioconversion rates related to diversified chemical spaces and might not be a suitable tool for phosphate prodrug screening.
In conclusion, the intestinal mucosa scraps reserved the highest ALP activities and demonstrated as a promising in vitro tool for screening the bioconversion of phosphate prodrug. MDCK shows the promising on labor saving as a predictive tool for drug absorption, however, it might not replace Caco-2 cells for the investigation of phosphate prodrugs due to lack of efficient ALP mediated bioconversion. The special value of Caco-2 cell model is that Caco-2 cells might not only provide the predictive This article has not been copyedited and formatted. The final version may differ from this version. This article has not been copyedited and formatted. The final version may differ from this version. This article has not been copyedited and formatted. The final version may differ from this version. 
